Hält derzeit Positionen bei FibroGen Inc and Intra-Cellular Therapies Inc
Position | Company | Period |
---|---|---|
Independent Director | FibroGen Inc | 1. Oktober 1993 - |
Independent Director | Intra-Cellular Therapies Inc | 1. Januar 2014 - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-14 | 2023-12-12 |
Calyxt Inc
(CLXT)
|
K Kauf |
517.107
+46.8%
10,585.470.992 USD |
517.107 +46.8% | 10,58 | 5.470.992 USD | |
2023-06-02 | 2023-06-01 |
Calyxt Inc
(CLXT)
|
K Kauf |
1.000
+0.1%
31,5031.500 USD |
1.000 +0.1% | 31,50 | 31.500 USD | |
2023-05-22 | 2023-05-22 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
1.750.000
-99.6%
32,8257.435.000 USD |
1.750.000 -99.6% | 32,82 | 57.435.000 USD | |
2023-03-30 | 2023-03-30 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
130.024
-8.2%
36,264.714.345 USD |
130.024 -8.2% | 36,26 | 4.714.345 USD | |
2023-03-30 | 2023-03-29 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
9.926
-0.6%
36,95366.766 USD |
9.926 -0.6% | 36,95 | 366.766 USD | |
2022-12-13 | 2022-12-09 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
19.990
-12.8%
42,07840.939 USD |
19.990 -12.8% | 42,07 | 840.939 USD | |
2022-11-21 | 2022-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
120.000
-43.4%
42,335.079.924 USD |
120.000 -43.4% | 42,33 | 5.079.924 USD | |
2022-09-15 | 2022-09-15 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
52.025
-15.8%
42,212.195.960 USD |
52.025 -15.8% | 42,21 | 2.195.960 USD | |
2022-09-15 | 2022-09-14 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
47.975
-12.7%
42,412.034.428 USD |
47.975 -12.7% | 42,41 | 2.034.428 USD | |
2022-08-11 | 2022-08-09 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
45.000
-10.7%
43,731.967.823 USD |
45.000 -10.7% | 43,73 | 1.967.823 USD | |
2022-05-23 | 2022-05-20 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
123.696
-21.5%
39,284.858.655 USD |
123.696 -21.5% | 39,28 | 4.858.655 USD | |
2022-05-23 | 2022-05-19 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
26.304
-4.4%
40,091.054.651 USD |
26.304 -4.4% | 40,09 | 1.054.651 USD | |
2022-03-30 | 2022-03-29 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
60.000
-9.1%
38,592.315.322 USD |
60.000 -9.1% | 38,59 | 2.315.322 USD | |
2022-03-21 | 2022-03-21 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
14.322
-100.0%
39,05559.288 USD |
14.322 -100.0% | 39,05 | 559.288 USD | |
2022-03-21 | 2022-03-21 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
25.545
-100.0%
39,05997.558 USD |
25.545 -100.0% | 39,05 | 997.558 USD | |
2022-03-21 | 2022-03-18 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
56.181
-39.7%
39,772.234.094 USD |
56.181 -39.7% | 39,77 | 2.234.094 USD | |
2022-03-21 | 2022-03-18 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
26.238
-64.7%
39,381.033.334 USD |
26.238 -64.7% | 39,38 | 1.033.334 USD | |
2022-03-21 | 2022-03-18 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
46.803
-64.7%
39,381.843.247 USD |
46.803 -64.7% | 39,38 | 1.843.247 USD | |
2022-03-18 | 2022-03-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Verkauf |
15.736
-100.0%
61,35965.352 USD |
15.736 -100.0% | 61,35 | 965.352 USD | |
2022-03-18 | 2022-03-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Verkauf |
4.901
-23.7%
60,63297.154 USD |
4.901 -23.7% | 60,63 | 297.154 USD | |
2022-03-18 | 2022-03-17 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Verkauf |
114.912
-84.8%
60,416.941.570 USD |
114.912 -84.8% | 60,41 | 6.941.570 USD | |
2022-03-18 | 2022-03-17 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Verkauf |
26.587
-16.4%
59,991.595.076 USD |
26.587 -16.4% | 59,99 | 1.595.076 USD | |
2022-03-18 | 2022-03-16 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Verkauf |
43.848
-21.3%
59,532.610.057 USD |
43.848 -21.3% | 59,53 | 2.610.057 USD | |
2022-03-18 | 2022-03-16 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Verkauf |
20.686
-9.1%
58,721.214.771 USD |
20.686 -9.1% | 58,72 | 1.214.771 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
31.341
-2.7%
42,331.326.636 USD |
31.341 -2.7% | 42,33 | 1.326.636 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
38.815
-2.1%
42,351.643.749 USD |
38.815 -2.1% | 42,35 | 1.643.749 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
69.233
-12.2%
42,352.931.900 USD |
69.233 -12.2% | 42,35 | 2.931.900 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
62.435
-9.1%
42,392.646.401 USD |
62.435 -9.1% | 42,39 | 2.646.401 USD | |
2021-11-18 | 2021-11-16 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
12.565
-1.8%
42,01527.805 USD |
12.565 -1.8% | 42,01 | 527.805 USD | |
2021-06-29 | 2021-06-29 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
479.800
-12.2%
41,2619.794.437 USD |
479.800 -12.2% | 41,26 | 19.794.437 USD | |
2021-06-29 | 2021-06-29 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
1.200
-0.0%
42,0150.409 USD |
1.200 -0.0% | 42,01 | 50.409 USD | |
2021-06-29 | 2021-06-28 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
167.448
-4.1%
42,117.051.269 USD |
167.448 -4.1% | 42,11 | 7.051.269 USD | |
2021-06-29 | 2021-06-25 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
487.364
-10.6%
42,6920.807.519 USD |
487.364 -10.6% | 42,69 | 20.807.519 USD | |
2021-06-29 | 2021-06-25 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
179.100
-16.1%
42,817.666.501 USD |
179.100 -16.1% | 42,81 | 7.666.501 USD | |
2020-10-22 | 2020-10-20 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
463.200
-100.0%
42,0019.454.400 USD |
463.200 -100.0% | 42,00 | 19.454.400 USD | |
2020-06-23 | 2020-06-18 |
Royalty Pharma PLC
(RPRX)
|
K Kauf |
15.000
+inf%
28,00420.000 USD |
15.000 +inf% | 28,00 | 420.000 USD | |
2022-12-13 | 2002-12-12 |
Royalty Pharma PLC
(RPRX)
|
V Verkauf |
40.010
-29.3%
41,981.679.684 USD |
40.010 -29.3% | 41,98 | 1.679.684 USD |